SMTL ID : 9h1e.1

Crystal structure of Angiotensin-1 converting enzyme C-domain in complex with dual ACE/NEP inhibitor AD016

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.45 Å

Oligo State

monomer

Ligands

1 x NAG- NAG- BMA- MAN- FUC: alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose

NAG-NAG-BMA-MAN-FUC.1: 9 residues within 4Å: Chain A: S.9, V.12, E.13, N.73, T.75, I.76, L.361, P.362, L.365 4 PLIP interactions: 4 interactions with chain A Hydrophobic interactions: A:V.12, A:E.13, A:I.76 Hydrogen bonds: A:E.13

1 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG.2: 5 residues within 4Å: Chain A: N.36, T.38, E.40, T.41, R.312 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:N.36, A:T.38

1 x BO3: BORIC ACID(Non-covalent)

BO3.3: 7 residues within 4Å: Chain A: Y.110, L.125, W.243, H.317, K.475, F.476 Ligands: 01.9 8 PLIP interactions: 8 interactions with chain A Hydrogen bonds: A:Y.110, A:Y.110, A:H.317, A:K.475, A:F.476 Water bridges: A:E.126, A:E.126, A:Q.245

2 x MLA: MALONIC ACID(Non-covalent)

MLA.4: 8 residues within 4Å: Chain A: K.442, E.443, N.444, Y.445, N.446, Q.447, Q.467, G.468 5 PLIP interactions: 5 interactions with chain A Hydrogen bonds: A:K.442, A:N.446, A:Q.447, A:Q.467 Water bridges: A:Q.447 MLA.5: 10 residues within 4Å: Chain A: E.87, R.88, Y.99, I.168, A.171, A.172, N.175, A.180, S.183, W.184 9 PLIP interactions: 9 interactions with chain A Hydrophobic interactions: A:E.87, A:A.171 Hydrogen bonds: A:E.87, A:E.87, A:Y.99, A:N.175, A:W.184 Water bridges: A:R.88, A:S.183

1 x ZN: ZINC ION(Non-covalent)

ZN.6: 5 residues within 4Å: Chain A: H.347, H.351, E.375, Y.487 Ligands: 01.9 3 PLIP interactions: 3 interactions with chain A Metal complexes: A:H.347, A:H.351, A:E.375

2 x CL: CHLORIDE ION(Non-functional Binders)

CL.7: 6 residues within 4Å: Chain A: W.146, R.150, W.449, W.450, R.453, D.471 Ligand excluded by PLIP CL.8: 5 residues within 4Å: Chain A: Y.188, P.371, P.483, I.485, R.486 Ligand excluded by PLIP

1 x 01: (2~{S})-2-[[(2~{S})-6-azanyl-2-[[(2~{S})-3-phenyl-2-sulfanyl-propanoyl]amino]hexanoyl]amino]-3-(1~{H}-indol-3-yl)propanoic acid

01.9: 24 residues within 4Å: Chain A: Q.245, T.246, H.317, A.318, S.319, A.320, E.340, V.343, V.344, H.347, E.348, H.351, E.375, D.379, F.421, K.475, F.476, H.477, V.482, Y.484, Y.487, F.491 Ligands: BO3.3, ZN.6 16 PLIP interactions: 16 interactions with chain A Hydrophobic interactions: A:A.318, A:H.347, A:F.421, A:F.476, A:V.482, A:Y.487 Hydrogen bonds: A:Q.245, A:A.318, A:H.477 Water bridges: A:N.241, A:E.340, A:K.475 Salt bridges: A:H.317, A:K.475, A:H.477 pi-Stacking: A:H.347

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Cozier, G.E. et al., Design of Novel Mercapto-3-phenylpropanoyl Dipeptides as Dual Angiotensin-Converting Enzyme C-Domain-Selective/Neprilysin Inhibitors. J.Med.Chem. (2025)

Release Date

2025-04-16

Peptides

Angiotensin-converting enzyme: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Angiotensin-converting enzyme

Related Entries With Identical Sequence